Cellular Health & the Hallmarks of Ageing

Summary

Cellular ageing is not one process but a set of interacting ones, formalised in the widely cited hallmarks of ageing framework. Understanding those hallmarks is the difference between reading longevity research critically and taking marketing claims at face value. This page explains each hallmark and how researchers measure it.

Last reviewed 2026-09-01

What it is

The hallmarks of ageing are a set of cellular and molecular processes that accumulate with age, contribute causally to functional decline, and whose modulation alters the ageing trajectory in model organisms.

The framework was published by López-Otín and colleagues in Cell in 2013 with nine hallmarks, and expanded to twelve in a 2023 update that added disabled macroautophagy, chronic inflammation and dysbiosis.

It was modelled on the earlier hallmarks of cancer framework, which reorganised a fragmented field around a small set of unifying processes.

It gives researchers, and readers, a way to ask of any longevity claim: which hallmark does this address, and by what measurable endpoint?

How it works

In plain terms

Cells accumulate damage in a handful of specific ways: their DNA gets damaged, their chromosome caps shorten, their recycling systems slow, they stop dividing but do not die, and their communication becomes noisy. Ageing is what those changes add up to.

Technical detail

Primary hallmarks represent damage: genomic instability, telomere attrition, epigenetic alterations, loss of proteostasis and disabled macroautophagy. Antagonistic hallmarks are compensatory responses that become harmful when chronic: deregulated nutrient sensing (mTOR, AMPK, insulin/IGF-1 signalling), mitochondrial dysfunction and cellular senescence. Integrative hallmarks are the resulting phenotypes: stem cell exhaustion, altered intercellular communication, chronic inflammation and dysbiosis. The categories are hierarchical — damage drives compensation, which produces phenotype.

Pathways involved

Genomic instability and DNA repair capacity
Telomere attrition and replicative senescence
Epigenetic drift and methylation clocks
Proteostasis, chaperones and macroautophagy
Nutrient sensing: mTOR, AMPK, insulin/IGF-1
Senescent cell burden and SASP signalling

Current research

Laboratory research

Cell culture models such as replicative senescence in fibroblasts and induced senescence via irradiation underpin most mechanistic work. Epigenetic clock development is done on large human methylation datasets.

Animal research

Interventions targeting individual hallmarks — senolytics, rapamycin, caloric restriction, partial reprogramming with Yamanaka factors — extend lifespan or healthspan in mice, with effect sizes varying by sex, strain and start age.

Human research

Human evidence is mostly observational and biomarker-based. Epigenetic clocks correlate with mortality risk in cohort studies. Interventional human trials targeting hallmarks are small and short: senolytic pilot studies in idiopathic pulmonary fibrosis and diabetic kidney disease, and metformin and rapamycin trials with surrogate endpoints.

Ongoing research

The TAME trial concept for metformin and various senolytic Phase 2 programmes are the most-watched human efforts.

What is being investigated

Senescent cell clearance and its effect on tissue function
Epigenetic reprogramming to reset cellular age markers
Autophagy induction through fasting, exercise and pharmacology
Nutrient-sensing modulation via mTOR and AMPK
Stem cell exhaustion and regenerative capacity

These are research directions reported in the literature, not established effects or recommendations.

Risks, limitations and unknowns

Read this section before the rest

Lifespan extension in mice has repeatedly failed to translate to humans
Biomarker improvement is not the same as improved health outcome
Most human data is observational and subject to healthy-user bias
Interventions targeting one hallmark can worsen another — for example, suppressing mTOR affects immune function and muscle protein synthesis
Commercial longevity claims frequently cite hallmark mechanisms without any outcome data

Evidence ratings

Laboratory studies

Strong

Hallmark mechanisms extensively characterised.

Animal studies

Strong

Multiple interventions extend murine lifespan reproducibly.

Human studies

Limited

Mostly observational; few interventional trials with hard endpoints.

Long-term safety

Limited

Chronic modulation of these pathways is poorly characterised in humans.

References

[1]Hallmarks of Ageing (2013) and 2023 update — PubMed / Cell, 2013, 2023
[2]Cellular senescence and senolytics — PubMed, 2015–present
[3]Epigenetic clocks and mortality — PubMed, 2013–present
Reference links open searches and records on PubMed and ClinicalTrials.gov so that every statement above can be traced to primary literature.

Frequently asked questions

What are the hallmarks of ageing?+

A framework of twelve interacting cellular processes — from genomic instability to chronic inflammation — that accumulate with age and causally contribute to decline.

Who defined the hallmarks of ageing?+

López-Otín and colleagues, published in Cell in 2013 and expanded in 2023.

What is cellular senescence?+

A state in which a cell permanently stops dividing but remains metabolically active, often secreting inflammatory factors known as the senescence-associated secretory phenotype.

Do senolytics work in humans?+

Small pilot trials report changes in senescence markers and some functional measures. No adequately powered outcome trial has been completed.

Is telomere length a good ageing marker?+

It correlates with age at population level but is a poor individual predictor, and measurement methods vary widely in reliability.

What is autophagy?+

The cell's process for breaking down and recycling damaged components. Its decline was added to the hallmarks framework in 2023.

Does caloric restriction extend human lifespan?+

It extends lifespan in several model organisms. Human data, including the CALERIE trial, shows biomarker improvements but no lifespan evidence.

Can ageing be reversed?+

Partial epigenetic reprogramming reverses certain age markers in mice, in specific tissues, with tumour risk as a known hazard. Nothing comparable is established in humans.

How is biological age measured?+

Most commonly with DNA methylation clocks, alongside composite biomarker panels. These are research tools with meaningful measurement error at individual level.

Continue your research

Mitochondrial function

Ageing biomarkers

Chronic inflammation